[Leish-l] inquiry

Hiro Goto hgoto at usp.br
Fri Jun 3 12:00:16 BRT 2011


Dear all,
The discussion is becoming more and more interesting. We observe  
changes in disease manifestations in Brazil with an increase in the  
lethality that we do not know if it is due to the parasite strain  
differences. I am copying this e-message to collaborators that are  
analysing strain variations in isolates from different parts of Brazil.
Regards,
Hiro

Citando Patrick Bastien <patrick.bastien at univ-montp1.fr>:

> Dear Petr,
>
> Two comments :
> 1) I am curious to know how you define a hybrid between L. infantum   
> and L. donovani, knowing that these species are quite difficult to   
> differentiate by simple sequence analysis. Is it using the MLST  
> method  described in your paper attached ? Are the genes you are  
> using single  copy or duplicated ? Have you used isoenzymes for  
> confirmation ?
>
> 2) Talking of such, I am always puzzled when I see efforts for   
> correlating molecular and isoenzyme-based phenogramms (Fig. 4, your   
> article attached). Worse, your text clearly states that the strains   
> analyzed are "unambiguously distinct from the MON-1 zymodeme (...)  
> of  L. infantum". This is particularly risky, as it is to use  
> zymodeme  names (MON-...) in a phylogenetic reconstruction using  
> other intrinsic  (here molecular) criteria. Indeed, a zymodeme may  
> include different  genotypes and a genotype may theoretically cover  
> several zymodemes. A  zymodeme is nothing else than an "operational  
> taxonomic unit" used for  classification (phenetics) (see the famous  
> paper by Rioux et al.  attached); as such, it has no biological nor  
> evolutionary signification.
> Similarly, when you write "Among accessible isolates typed using the  
>  MLST method, our strain is close to MON-188, the L. infantum strain  
>  isolated by Gramiccia (Pratlong et al., 2003)(...)", the MON-... is  
>  abusively assimilated to a given strain (here ISS800), whereas one   
> zymodeme normally clusters several strains, that might be found   
> clustered differently using your method or another method.
> Another important point is that the MON-... is defined by the   
> examination of a series of 15 given iso-enzymes, but this is also   
> dependent upon the technique used (and, to a lesser degree, to the   
> person/research group who defines it). That is why Rioux et al.   
> recommended that each identifying center use its own code (such as   
> MON- for Montpellier or LON- for London). Indeed, MON-188 in   
> Montpellier migh tbe different from MON-188 in another center if the  
>  system used is not exactly the same.
> All this may seem trivial, but there is a real danger, as it slowly   
> introduces in the minds of our colleagues scientists that different   
> classifications are equivalent.
> I know that I am touching on a question which can yield hours of   
> debate and thousands of e-mails; so, although I am sure you will  
> want  to reply to this, please note that I do not want to lauch such  
> a  debate online !
>
> Best wishes
> Patrick
>
> Professeur Patrick Bastien
> Laboratoire de Parasitologie-Mycologie, Faculté de Médecine
> UMR MIVEGEC (CNRS 5290 - IRD 224 - Université Montpellier 1)
> Centre National de Référence des Leishmania
> CHU de Montpellier
> 39 Avenue Charles Flahault
> 34295 Montpellier Cedex 5, France
>
> Petr Volf <volf at cesnet.cz> a écrit :
>
>> Re: [Leish-l] inquiryHi K.P.,
>> in Cukurova region, Turkey, cutaneous L. infantum (now it seems  
>> that   we are dealing with L.donovani/L. infantum hybrid) grew very  
>>  poorely  if we isolated them from patients. Only 1 of 25  
>> isolations  was  succesfull. However, the same strain (confirmed by  
>> molecular   methods) grew repeatedly and very well if we isolated  
>> them from   sandflies. It might be useful for Dr. Sharma try to get  
>> isolates   from sand flies. It is very laborious but very useful,  
>> in Cukurova   we got about dozen of isolates by this method (all  
>> identical).
>> Patients are rK39 negative, see attached paper.
>> Best wishes
>> Petr
>>  ----- Original Message -----
>>  From: Chang, Kwang-Poo
>>  To: Sharman ; Hiro Goto ; elfadil abass
>>  Cc: leish-l at lineu.icb.usp.br
>>  Sent: Sunday, May 22, 2011 1:39 AM
>>  Subject: Re: [Leish-l] inquiry
>>
>>
>>  Dr. NL Sharma has been working on an important CL endemic area    
>> along the Satluj River valley to the south of Himalaya in India    
>> (Please correct me should I be wrong for anything I said here and    
>> below). I had the good fortune of visiting the site several years    
>> back courtesy of Dr. Sharma.
>>
>>  I believe Dr. Sharma's finding is important, since the parasites    
>> there are different from the familiar Indian L donovani in Bihar.    
>> The parasites are refratory to in vitro cultivation. They do    
>> differentiate into promastigotes and may grow a little, but  can't   
>>  really be subcultured to establish passageable lines. This is very  
>>   much reminescent of L infantum in the Mediterranean area. I  
>> recall   Dr. Sharma has also found rK39+ dogs, if I remember  
>> correctly. If   so,  Satluj river valley is endemic to the  
>> infantile CL.
>>
>>  Analyses of several batches of basically clinical CL samples from   
>>  Dr. Sharma showed evidence of L infantum, but also L tropica as  
>> well   as a mixture of the two in one sample. This is the same  
>> picture we   have noted for samples from Hatay, Turkey.
>>
>>  These observations make me wonder a lot about our current    
>> knowledge on the clinico-epidemiology based on data collected    
>> previously by analyses of cultured promastigotes from one or few    
>> 'representative samples'. Nowaday, technology makes it very doable   
>>  to work with biological samples for Leish DNAs directly from sand   
>>  flies, patients and reservoir animals.
>>
>>  KP
>>
>>
>>
>> ------------------------------------------------------------------------------
>>  From: leish-l-bounces at lineu.icb.usp.br on behalf of Sharman
>>  Sent: Fri 5/20/2011 11:31 PM
>>  To: Hiro Goto; elfadil abass
>>  Cc: leish-l at lineu.icb.usp.br
>>  Subject: Re: [Leish-l] inquiry
>>
>>
>>  Dear all
>>  I agree with Hiro gito, We are working on a focus where the CL is
>>  predominantly caused by L. donovani, and the rK 39 STRIPS GIVE POSITIVE
>>  RESULTS WITH SERA as well as serous exudate from the lesion. The    
>> results are
>>  dependent upon species.
>>  NL Sharma
>>
>>  --------------------------------------------------
>>  From: "Hiro Goto" <hgoto at usp.br>
>>  Sent: Wednesday, May 18, 2011 12:09 AM
>>  To: "elfadil abass" <elfadil_abass at yahoo.com>
>>  Cc: <leish-l at lineu.icb.usp.br>
>>  Subject: Re: [Leish-l] inquiry
>>
>>  > Dear all,
>>  > In our oppinion, DAT and rK39 for those samples are not indicated  since
>>  > these tests are produced for the diagnosis of visceral  leishmaniasis.
>>  > In case of tegumentary leishmaniasis, it is very appropriate the
>>  > observation of J.J. Shaw appointing species specificity of antibody
>>  > response in these cases. Titers of antibodies are in general low  
>>   in  these
>>  > cases therefore depending on the species, it may result     
>> negative. We have
>>  > published a review recently in Expert Rev. Anti  Infect. Ther. 8(4),
>>  > 419?433 (2010), Current diagnosis and treatment of  cutaneous and
>>  > mucocutaneous leishmaniasis, where we raise this point.
>>  > Hiro Goto
>>  >
>>  > Citando elfadil abass <elfadil_abass at yahoo.com>:
>>  >
>>  >> Dear all I would recommend using DAT and rK39 strip test to measure
>>  >> antibody
>>  >> responses and to evaluate the diagnostic efficiency for both tests  in
>>  >> such group
>>  >> of patients.
>>  >>
>>  >>  Elfadil Abass
>>  >>    
>> ________________________________________________________________________________
>>  >> Institute of Medical Microbiology and Hospital Hygiene
>>  >> Philipps University Marburg
>>  >> BMFZ / Hans-Meerwein Straße 2
>>  >> D-35033 Marburg, Germany
>>  >>    
>> ________________________________________________________________________________
>>  >>
>>  >>
>>  >>
>>  >>
>>  >> ________________________________
>>  >> From: Nuha Nuwayri-Salti <racha at aub.edu.lb>
>>  >> To: saad saad <saad1426 at gmail.com>; "leish-l at lineu.icb.usp.br"
>>  >> <leish-l at lineu.icb.usp.br>
>>  >> Sent: Fri, May 13, 2011 9:39:33 AM
>>  >> Subject: Re: [Leish-l] inquiry
>>  >>
>>  >> Dear Saad first precaution to take is to separate your samples into
>>  >> several
>>  >> portions each (at least 5 each being no more than a few hundred(200-400)
>>  >> microliters). This is a necessary precaution to avoid freezing and
>>  >> thawing
>>  >> several times the same sample which will be the case should you do
>>  >> different
>>  >> studies at different times which is unavoidable.
>>  >>
>>  >> What you can do is correlate the type(ulcerated, abscess, furuncle
>>  >>  etc.. ) the
>>  >> locale, the number and age of lesions with the levels of    
>> antibody in  the
>>  >> sera of
>>  >> these patgients and also monitor cell mediated immunity with leishmanin
>>  >> skin
>>  >> test!
>>  >> I have just published (in print) an article about having circulating
>>  >> parasites
>>  >> in some of these patients with apparently pure cutaneous disease. It is
>>  >> the
>>  >> first paper that revealed this fact. It would be interesting to confirm
>>  >> or
>>  >> de-confirm this fact repeating what we did.
>>  >> Best wishes
>>  >>
>>  >> Nuha Nuwayri-Salti MD
>>  >>
>>  >>
>>  >>
>>  >> AOA
>>  >> Medical Honor Society
>>  >>
>>  >>
>>  >>
>>  >>
>>  >> -----Original Message-----
>>  >> From: leish-l-bounces at lineu.icb.usp.br
>>  >> [mailto:leish-l-bounces at lineu.icb.usp.br]
>>  >> On Behalf Of saad saad
>>  >> Sent: Friday, April 29, 2011 11:23 PM
>>  >> To: leish-l at lineu.icb.usp.br
>>  >> Subject: [Leish-l] inquiry
>>  >>
>>  >> Dear all
>>  >> Hi. i am Saad from Saudi Arabia. i have 60 sera from positive case of
>>  >> CL from south west of the country. I would like to have your
>>  >> recommendations to start a good research line in CL using these sera.
>>  >> Thanks in advance for your help
>>  >> _______________________________________________
>>  >> Leish-l mailing list
>>  >> Leish-l at lineu.icb.usp.br
>>  >> http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l
>>  >> _______________________________________________
>>  >> Leish-l mailing list
>>  >> Leish-l at lineu.icb.usp.br
>>  >> http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l
>>  >>
>>  >
>>  >
>>  >
>>  > Profa. Dra. Hiro Goto
>>  > Laboratório de Soroepidemiologia e Imunobiologia
>>  > Instituto de Medicina Tropical de São Paulo, USP
>>  > Av. Dr. Enéas de Carvalho Aguiar, 470, prédio II, quarto andar
>>  > 05403-000 - São Paulo, SP
>>  > Tel. +55-11-3061 7023, 3061 7056 ou 3061 7027
>>  > Fax. +55-11-3061-8270
>>  >
>>  > _______________________________________________
>>  > Leish-l mailing list
>>  > Leish-l at lineu.icb.usp.br
>>  > http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l
>>  >
>>  _______________________________________________
>>  Leish-l mailing list
>>  Leish-l at lineu.icb.usp.br
>>  http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l
>>
>>
>>
>>
>> ------------------------------------------------------------------------------
>>
>>
>>  _______________________________________________
>>  Leish-l mailing list
>>  Leish-l at lineu.icb.usp.br
>>  http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l
>>
>
>
>



Profa. Dra. Hiro Goto
Laboratório de Soroepidemiologia e Imunobiologia
Instituto de Medicina Tropical de São Paulo, USP
Av. Dr. Enéas de Carvalho Aguiar, 470, prédio II, quarto andar
05403-000 - São Paulo, SP
Tel. +55-11-3061 7023, 3061 7056 ou 3061 7027
Fax. +55-11-3061-8270



More information about the Leish-l mailing list